The E2 protein of high risk human papillomavirus type 16 (HPV16) contains an amino-terminal (N) domain, a hinge (H) region and a carboxyl-terminal (C) DNA-binding domain. Using enhanced green fluorescent protein (EGFP) fusions with full length E2 and E2 domains in transfection assays in HeLa cells, we found that the C domain is responsible for the nuclear localization of E2 in vivo, whereas the N and H domains do not contain additional nuclear localization signals (NLSs). Deletion analysis of EGFP-E2 and EGFP-cE2 determined that the C domain contains an α helix cNLS that overlaps with the DNA-binding region. Mutational analysis revealed that the arginine and lysine residues in this cNLS are essential for nuclear localization of HPV16 E2. Interestingly, these basic amino acid residues are well conserved among the E2 proteins of BPV-1 and some high risk HPV types but not in the low risk HPV types, suggesting that there are differences between the NLSs and corresponding nuclear import pathways between these E2 proteins.
The papillomavirus E2 proteins have major functions during the viral life cycle in the regulation of viral DNA replication together with E1 and in transcriptional activation or repression. E2 can function either as an activator of viral transcription at low concentrations or as a repressor at high concentrations when it interferes with the binding of transcription factors such as TFIID and Sp1 (reviewed in Longworth and Laimins, 2004) . In addition, E2 plays an essential role in viral genome segregation by tethering the viral DNA to the mitotic chromosomes, and in the case of bovine papillomavirus (BPV) type 1 E2 protein, this process is mediated by the bromodomain protein Brd4 (Baxter et al., 2005; McBride et al., 2004; McPhillips et al., 2005; Oliveira et al., 2006; You et al., 2004) . The high risk types HPV16 and 18 E2 proteins have also proapoptotic activities (Demeret et al., 2003; Webster et al., 2000) . For HPV18 E2, this proapoptotic activity depends on the induction of the extrinsic pathway via caspase 8 activation in the cytoplasm Demeret et al., 2003) . Recently, the high risk HPV16/ 18 E2 proteins, but not the low risk types, have been shown to have the ability to induce genomic instability via a strong interaction with two activators of the Anaphase Promoting Complex (APC), Cdc20 and Cdh1 .
The full length E2 protein contains two functional domains connected by a flexible hinge (H) region and forms dimers via the C-terminal domain. The structures of both the N-terminal and C-terminal domains have been determined: the N domain consists of a bundle of α helices packed against a β-sheet framework (Harris and Botchan, 1999) , whereas the C-DNAbinding domain consists of a dimeric β-barrel structure with a pair of symmetrically disposed α helices that bind and bend the DNA (Hegde and Androphy, 1998; Hegde et al., 1992; Kim et al., 2000) . The N domain functions as a transactivation domain and can also recruit and bind the E1 helicase. The structure and functions of the N and C domains are relatively conserved among papillomaviruses, whereas the H region is variable both in sequence and length. Alternative promoter usage and mRNA splicing generate additional forms of the E2 polypeptides that contain intact H and C domains and either a truncated or substituted N domain (reviewed in Longworth and Laimins, 2004) .
Nucleocytoplasmic transport occurs through the nuclear pore complex, which is a large structure with an eight-fold symmetry. Nuclear import of macromolecules is signal-mediated, energyVirology 360 (2007) 191 -198 www.elsevier.com/locate/yviro dependent and highly selective. The first identified nuclear localization signals (NLSs), referred to as classical NLSs, fall into two categories: monopartite NLSs consisting of a simple sequence of 3-5 basic amino acid residues, and bipartite NLSs consisting of a basic dipeptide upstream (10-12 amino acids) from a simple basic sequence. Other types of NLSs have been identified in hnRNP proteins, ribosomal proteins, U snRNPs and viral proteins, while many others remain to be characterized. Most NLSs do not fit a well defined consensus, and for many, no consensus has been proposed (reviewed in Fried and Kutay, 2003; Moroianu, 1999) . Two NLSs have been identified in the BPV-1 E2 protein: residues 107 to 115 (RKCFKKGAR) in the N domain and residues 339-352 (KCYRFRVKKNHRHR) in the C domain (Skiadopoulos and McBride, 1996) . Partially homologous sequences are present in the E2 proteins of HPV types, although it is not clear if they actually function as NLSs. The E2 protein of low risk type HPV11 has been shown to contain a classic monopartite NLS in the hinge region, required for nuclear localization of HPV11 E2 and for its interaction with the nuclear matrix (Zou et al., 2000) . This HPV11 E2′ NLS is not conserved in the high risk HPV16 and HPV18 E2 proteins. In this study, we have identified and characterized the NLS of high risk HPV16 E2 protein using both in vivo and in vitro analysis of the intracellular localization of E2, E2 domains and different deletion and substitution variants.
Results
The C domain of HPV16 E2 is required for E2 nuclear localization in vivo
To determine the E2 domain(s) that mediates the nuclear localization of HPV16 E2, we generated EGFP fusion proteins containing either the full length E2 or the N domain together with the hinge (called nhE2) or the C domain (called cE2). HeLa cells were transiently transfected with either EGFP-E2, EGFPnhE2, EGFP-cE2 or EGFP itself, and after 24 h, the intracellular localization of the corresponding EGFP fusion proteins was examined by fluorescence microscopy. EGFP-E2 had strong nuclear localization, whereas EGFP itself was diffusely localized throughout the cell (Figs. 1A and G) . The EGFPcE2 had a similar nuclear localization as the full length E2, whereas the EGFP-nhE2 was mostly cytoplasmic (Figs. 1E and C) . Note that, although the EGFP is small enough to passively diffuse through the nuclear pore complex, the EGFP-E2 and EGFP-cE2 (both as dimers) are above the limit of passive diffusion and their nuclear localization requires NLS(s). Immunoblot analysis with an anti-GFP antibody of the translated EGFP-nhE2 and EGFP-cE2 fusion proteins indicated that they were intact (data not shown), excluding the possibility that the cytoplasmic localization of EGFP-nhE2 is due to protein degradation. These data suggest that the C domain is responsible for the nuclear localization of HPV16 E2 and that the N domain and hinge region do not contain additional NLSs. Note that in some cells the nuclear localization of EGFP-E2 and EGFP-cE2 showed some accumulation in sub-nuclear structures that are most likely nucleoli (Figs. 1A and E) . Nucleolar GFP fluorescence has been previously observed with GFP-E2 proteins from both the high risk types (16 and 18) and low risk types (6 and 11) .
To investigate if the C domain can mediate active nuclear import, we made a GST-cE2 fusion protein and tested it in in vitro nuclear import assays. Digitonin-permeabilized HeLa cells were incubated with either GST-cE2 or GST-NLS 16L1 (as a positive control) or GST (as a negative control) in the presence of either only transport buffer or exogenous HeLa cytosol. Both the GST-cE2 and GST-NLS 16L1 were efficiently imported into the nucleus in the presence of cytosol (Figs. 2B and D) , whereas the GST itself was not (Fig. 2F ). These data show that the C domain of HPV16 E2 can mediate active nuclear import of a GST reporter indicating the presence of a strong NLS. GST-cE2 was not imported in the absence of cytosol ( Fig. 2A) suggesting that E2 nuclear import is mediated by nuclear import receptor(s).
An α helix NLS located in the C domain mediates HPV16 E2 nuclear import
It has been previously shown that, in addition to an NLS located in the N domain, BPV1 E2 contains a cNLS (KCYRFRVKKNHRHR) in the C domain (Skiadopoulos and McBride, 1996) . This cNLS is only partially conserved in HPV16 E2 protein ( 298 LKCLRYRFKKH 308 ). To test if this potential cNLS is required for nuclear localization of HPV16 E2, we generated a deletion mutant, EGFP-E2ΔcNLS lacking this sequence. Analysis of the intracellular localization of EGFP-E2ΔcNLS after transfection of HeLa cells revealed that the deletion mutant is mislocalized in the cytoplasm in contrast to the wild type EGFP-E2 which is in the nucleus (Fig. 3A , compare panel C and A). Moreover, the same cytoplasmic localization of EGFP-E2ΔcNLS versus nuclear localization of EGFP-E2 was obtained after transfection of COS-1 cells (Fig. 3B, compare panel C and A) . Immunoblot analysis with an anti-GFP antibody of the expressed EGFP-E2 and EGFP-E2ΔcNLS revealed that the proteins were intact and not degraded (data not shown) indicating that the cytoplasmic localization of EGFPE2ΔcNLS is not due to degradation. Deletion of the cNLS also led to the cytoplasmic mislocalization of the C domain upon transfection of HeLa cells with the EGFP-cE2ΔcNLS expression plasmid (Fig. 4A , compare panel C and A). Together, these data suggest that the cNLS ( 298 LKCLRYRFKKH 308 ) is required for nuclear localization of HPV16 E2 and that there are no additional NLSs present in this E2 protein.
To determine if the cNLS is sufficient for active nuclear import, we made a GST-cNLS fusion protein and tested it in nuclear import assays. Digitonin-permeabilized HeLa cells were incubated with either GST-cNLS or GST-NLS 16L1 or GST in the presence of either transport buffer or HeLa cytosol. Although the GST-cNLS was imported into the nucleus in the presence of cytosol, the efficiency of import was reduced in comparison with the GST-NLS 16L1 (Fig. 5, compare panel B and D) or GST-cE2 (Fig. 2B) . To determine the amino acids in the cNLS required for nuclear localization, we generated the following alanine and glutamic acid substitutions of the basic residues in the cNLS (in bold) in the context of both EGFP-E2 and EGFP-cE2: LKCLAAAFKKH (called sb1), LKCLRYRFAAH (called sb2), LKCLEEEFKKH (called sb3) and LKCLRYRFEEH (called sb4). We then analyzed the effect of these mutations on the intracellular localization of EGFP-E2 and EGFP-cE2 after transient transfection of HeLa cells.
The sb1 mutation in the cNLS (RYR to AAA) inhibited the nuclear localization of both E2 and the cE2 domain, leading to a diffuse localization throughout the cell of the EGFP-E2(sb2) and EGFP-cE2(sb2) mutants (Figs. 6A and B, panels C), in contrast with the nuclear localization of EGFP-E2 and EGFPcE2 (Figs. 6A and B, panels A) . The sb2 mutation in the cNLS (KK to AA) disrupted the nuclear localization of E2 leading to mostly cytoplasmic mislocalization of the EGFP-E2(sb2) (Fig. 7C) . Surprisingly, when we analyzed the intracellular localization of EGFP-cE2(sb2) in comparison with the wild type EGFP-cE2 in HeLa cells, there was only a modest effect of the sb2 mutation on the nuclear localization of EGFP-cE2(sb2) (Fig. 7 , compare panel G and E).
Substitutions of either the RYR or KK residues to glutamic acid residues completely disrupted the nuclear localization of E2 leading to cytoplasmic mislocalization of the EGFP-E2(sb3) and EGFP-E2(sb4) in HeLa cells (Figs. 8B and C) .
Discussion
In this study, we have identified a cNLS ( 298 LKCLRYRF-KKH 308 ) located in the C domain that is essential for the nuclear localization of HPV16 E2 protein in vivo. HPV16 E2′ cNLS overlaps with the α recognition helix which contains the amino acids involved in the interaction with the DNA (Hegde and Androphy, 1998) . Using mutational-function analysis in vivo, we determined that both the RYR motif and the KK residues in the cNLS ( 298 LKCLRYRFKKH 308 ) are critical for the nuclear localization of HPV16 E2. The difference in the effect of the mutations of KK to AA in the cNLS on the intracellular localization of the EGFP-cE2(sb2) (mostly nuclear) versus EGFP-E2(sb2) (mostly cytoplasmic) could be due to the fact that these substitutions may impair cE2 dimerization. In such a case, the EGFP-cE2(sb2) (as a monomer) would be below the passive diffusion limit of the nuclear pore complex and may enter the nucleus even with a defective NLS, whereas the dimeric EGFP-E2 is above this limit and requires a functional NLS. Interestingly, the K residues are conserved in the E2 proteins of BPV-1 and some high risk HPV types (16, 18, 45 and 70) ( Table 1) but not in other high risk HPV types (such as 31, 33, 52 and 56). These basic K residues are also not conserved in the low risk HPV E2 proteins; in the HPV11 E2 and HPV6A/6B E2, the KK residues are substituted with ND residues (Table  1 ). This correlates with the finding that in HPV11 E2 the sequence (LKCFRYRLND) does not function in nuclear localization of E2; instead, HPV11 E2 contains a classical monopartite NLS (hNLS = RKRAR) located in the H region that mediates nuclear localization of this E2 protein (Zou et al., 2000) . This hNLS is conserved in other low risk types, but not in the high risk types HPV16 and 18 E2 proteins (Zou (Table 1 ) which is conserved among fibropapillomaviruses (Skiadopoulos and McBride, 1996) . BPV-1 E2 contains also an NLS located in the N domain (nNLS = RKCFKKGAR) (Skiadopoulos and McBride, 1996) which is not conserved in either the high risk HPV16 E2 or the low risk HPV11 E2. The difference in the NLSs of different papillomavirus E2 proteins suggests that they use different karyopherins/importins and nuclear import pathways.
Although the α helix cNLS is essential for nuclear localization of HPV16 E2, we cannot exclude the possibility Fig. 6 . Mutational-function analysis of the cNLS of HPV16 E2 in vivo. HeLa cells were transfected with either EGFP-E2 (A, panels A and B), or EGFP-E2(sb1) (A, panels C and D), or EGFP-cE2 (B, panels A and B), or EGFP-cE2(sb1) (B, panels C and D), or EGFP (B, panels E and F) plasmids and examined by fluorescence microscopy at 24 h post transfection. Panels A, C, and E represent the fluorescence of the EGFP and panels B, D and F the DAPI staining of the nuclei. Fig. 7 . Mutational-function analysis of the cNLS of HPV16 E2 in vivo. HeLa cells were transfected with either EGFP-E2 (panels A and B), or EGFP-E2(sb2) (panels C and D), or EGFP-cE2 (panels E and F), or EGFP-cE2(sb2) (panels G and H), or EGFP (panels J and K) plasmids and examined by fluorescence microscopy at 24 h post transfection. Panels A, C, E, G and J represent the fluorescence of the EGFP and panels B, D, F, H and K the DAPI staining of the nuclei.
that additional residues outside this sequence may contribute to the complete cNLS function. In this respect, the nuclear import of the GST-cNLS in digitonin-permeabilized cells was less efficient than that of the GST-cE2. At least two reasons, which are not exclusive, could account for this: (1) additional residues are involved in the cNLS function and (2) most likely the α helix structure of the cNLS is not maintained when isolated out of the E2 protein context and may be essential for the interaction with the corresponding nuclear import receptor.
The E2 proteins exist in solution and bind to DNA as dimers. However, it is not clear if in the cell they dimerize in the cytoplasm and enter the nucleus as dimers or they enter as monomers and dimerize in the nucleus. In the first case, dimerization will lead to the presence of two NLSs which may function cooperatively in the nuclear import of E2.
Although the cNLS of HPV16 E2 contains basic residues and has sequence resemblance with classical monopartite NLSs, it is different in its structure as it is an α helix, whereas the classical NLSs bind to the karyopherins α in an extended conformation, as shown by structural studies (Chook and Blobel, 2001 ). The transcription factor PacC from the fungus Aspergillus nidulans also contains an α helix NLS that overlaps with the DNA-binding residues within the zinc finger domain of PacC (Fernandez-Martinez et al., 2003) . Although the PacC's NLS contains basic residues and resembles in sequence a monopartite NLS, it does not interact with the A. nidulans importin α (Fernandez-Martinez et al., 2003) . Future studies will lead to the identification of the nuclear import receptor(s) for the α helix cNLS of HPV16 E2 protein and the biochemical characterization of this nuclear import pathway.
Materials and methods

Generation of EGFP-E2, EGFP-nhE2 and EGFP-cE2 plasmids and mutagenesis
The enhanced green fluorescent protein (EGFP) expression plasmid pEGFP-C1 (Clontech, Inc.) was used to construct the EGFP fusion protein expression plasmids (EGFP-E2, EGFPcE2, GFP-E2ΔcNLS, EGFP-cE2ΔcNLS (Fig. 9) as follows. The pEGFP-C1 plasmid was double digested with EcoRI and SalI, run on a 0.7% agarose gel and the digested vector was extracted using the protocol from the QIAquick Gel Extraction Kit (Qiagen). DNA fragments spanning the full length HPV16 E2 or the C domain (cE2), or E2ΔcNLS, cE2ΔcNLS (lacking the potential cNLS, aa 298-308) were amplified using PCR oligonucleotides that added EcoRI and SalI restriction Table 1   HPV type  cNLS homologies   HPV16 E2  LKCLRYRFKKH  HPV18 E2  LKCLRYRLRKH  HPV45 E2  LKCLRYRLRK  HPV70 E2  LKCLRYRLRK  HPV11 E2  LKCFRYRLNDK  HPV6A/6B E2  LKCFRYRLNDK  BPV1 E2 VKCYRFRVKKNHRHR Fig. 9 . Schematic representation of deletion and substitution mutants of HPV16 E2 and its C domain used to make EGFP fusion proteins. endonuclease sites, and the PCR products were digested with EcoRI and SalI restriction enzymes and then ligated using T4 DNA ligase into the EcoRI and SalI cloning sites of pEGFP-C1. The resulting plasmids were used to transform XL1-Blue cells, and the purified plasmids were confirmed by sequencing (MGH DNA Sequencing Department). The EGFP-nhE2 (containing the N domain and H region of E2, aa 1-284) was generated using the QuikChange™ SiteDirected Mutagenesis Kit from Stratagene and mutated primers containing a stop codon at aa 285. The EGFP fusions containing mutations of the cNLS: EGFP-E2(sb1, substitution of RYR with AAA), EGFP-E2(sb2, substitution of KK with AA), EGFP-cE2(sb1), EGFP-cE2(sb2) (see Fig. 9 ), E2(sb3, substitution of RYR with EEE) and EGFP-E2(sb4, substitution of KK with EE), were generated using the QuikChange™ SiteDirected Mutagenesis Kit and the corresponding mutated primers. The constructs were used to transform XL1 blue bacteria, and the purified plasmids were confirmed by sequence analysis (MGH DNA Sequencing Department). The different E2 proteins used to make EGFP fusions are schematically represented in Fig. 9 .
Preparation of GST-cE2 and GST-cNLS
The GST-cNLS E2 fusion protein construct was prepared by fusing the cNLS sequence ( 298 LKCLRYRFKKH 308 ) to a GST reporter. To make the GST-cNLS construct, the corresponding forward and reverse oligonucleotides containing an EcoRI and XhoI restriction-cutting sites were annealed and inserted directly into the pGEX4T-1 vector which had been double cut with the same enzymes. The GST-cE2 construct was generated by inserting the PCR amplified cE2 fragment containing EcoRI and XhoI sites into the pGEX4T-1 vector which had been double cut with the same enzymes. Both the GST-cNLS and GST-cE2 constructs were transformed in XL1 blue bacteria and confirmed by automated sequence analysis (MGH DNA sequencing department). For protein expression, the GSTcNLS and GST-cE2 constructs were used to transform E. coli BL21 CodonPlus. After induction of the bacteria with 1 mM IPTG for 2 h at 30°C, the GST-cNLS and GST-cE2 fusion proteins were purified in native state on glutathione-Sepharose beads using a standard procedure. The GST-NLS HPV16L1 containing the monopartite NLS (AKRKKRKL) of HPV16 L1 major capsid protein was prepared as previously described (Nelson et al., 2003) . The proteins were checked for purity and lack of proteolytic degradation by SDS-PAGE and Coomassie Blue staining. The purified proteins were dialyzed in transport buffer (20 mM HEPES-KOH, pH 7.3, 110 mM potassium acetate, 2 mM magnesium acetate, 1 mM EGTA, 2 mM DTT, plus protease inhibitors) and stored in aliquots at − 80°C until use.
Transient expressions and fluorescence microscopy
HeLa cells (ATCC) and COS-1 cells (ATCC) were plated on 12 mm poly-L-lysine-coated glass coverslips to 50-70% confluency 24 h prior to transfection. Cells in each well were transfected with the corresponding EGFP-E2 plasmids (as indicated in figure legends) and FUGENE 6 (Roche Applied Science, IN) in 500 μl DMEM prepared following product protocol. Media was changed to DMEM with 10% FBS and pen-strep after 6 h, and the cells were fixed 24 h after the initial transfection with 10% formaldehyde in PBS (10 min). Coverslips were mounted using Vectashield-Dapi mounting medium (Vector Labs, CA) to identify the nuclei by DAPI staining and examined by fluorescence microscopy using a Nikon Eclipse TE 300 Microscope. All images were taken at the same exposure with a Sony DKC-5000 camera. The lower cytoplasmic level of the expressed EGFP-E2ΔcNLS and EGFP-cE2ΔcNLS (Figs. 3 and 4) could be due to either lower expression or less stability of these proteins when they are located in the cytoplasm. We did not notice that the EGFP-E2 fusion proteins induce apoptosis of the transfected HeLa cells in our conditions. This is in agreement with previous results where apoptosis was detectable only in cells infected at higher m.o.i. of HPV18 and HPV16 GFP E2-expressing recombinant adenoviruses .
Nuclear import assays
The nuclear import assays were carried out as previously described (Nelson et al., 2002) . Briefly, subconfluent HeLa cells, grown on poly-L-lysine coated glass coverslips for 24 h, were permeabilized with 70 μg/ml digitonin for 5 min on ice and washed with cold transport buffer. All import reactions contained an energy regenerating system (1 mM GTP, 1 mM ATP, 5 mM phosphocreatine and 0.4 U creatine phosphokinase), HeLa cytosol, and the different GST-fusion proteins (as indicated in the figure legends). Final import reaction volume was adjusted to 20 μl with transport buffer. For visualization of nuclear import, the GST fusion proteins were detected by immunofluorescence with an anti-GST antibody, as previously described (Nelson et al., 2002) . Coverslips were mounted using Vectashield-Dapi mounting medium (Vector Labs, CA) to identify the nuclei by DAPI staining. Nuclear import was analyzed with a Nikon Eclipse TE 300 Microscope that has a fluorescence attachment and a Sony DKC-5000 CCD camera.
